Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to estab...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2022/5766434 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832563892946993152 |
---|---|
author | Wenchang Yang Yaxin Wang Peng Zhang Tao Wang Chengguo Li Xin Tong Xiangyu Zeng Yuping Yin Kaixiong Tao Ruidong Li |
author_facet | Wenchang Yang Yaxin Wang Peng Zhang Tao Wang Chengguo Li Xin Tong Xiangyu Zeng Yuping Yin Kaixiong Tao Ruidong Li |
author_sort | Wenchang Yang |
collection | DOAJ |
description | 4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to establish an AIH-associated liver injury model. Furthermore, we investigated the effect of OI in Con A-induced liver injury and found that OI mitigated Con A-induced histopathological damage. OI administration reduced serum levels of alanine transaminase and aspartate transaminase in Con A-treated mice and attenuated the infiltration of macrophages induced by Con A. Moreover, OI effectively inhibited the expression of proinflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and IL-1β induced by Con A. Furthermore, OI decreased hepatocyte apoptosis and malondialdehyde levels and increased the reduced glutathione/oxidized glutathione ratio in the Con A-induced liver injury model. In addition, we found that OI inhibited Con A-induced hepatocyte apoptosis in vitro, while Nrf2 deletion eliminated this effect. Furthermore, we administrated the Nrf2 inhibitor ML385 in OI+Con A-treated mice and found that ML385 eliminated the protective effect of OI in vivo. In addition, OI inhibited Con A-induced activation of nuclear factor-kappa B (NF-𝜅B) and the expression of proinflammatory cytokines in macrophages. Therefore, OI protected mice from Con A-induced liver damage and may be associated with Nrf2 activation and NF-𝜅B inhibition. Finally, our study revealed that OI inhibited TNF-α, or supernatants from Con A-treated RAW264.7 cells induced hepatocyte apoptosis. In conclusion, our study indicated that OI alleviated Con A-induced hepatic damage by reducing inflammatory response, oxidative stress, and apoptosis. |
format | Article |
id | doaj-art-20bdf1b4c4154231b1269b73bde01315 |
institution | Kabale University |
issn | 1466-1861 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-20bdf1b4c4154231b1269b73bde013152025-02-03T01:12:14ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/5766434Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune HepatitisWenchang Yang0Yaxin Wang1Peng Zhang2Tao Wang3Chengguo Li4Xin Tong5Xiangyu Zeng6Yuping Yin7Kaixiong Tao8Ruidong Li9Department of Gastrointestinal SurgeryDepartment of Critical Care MedicineDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal SurgeryDepartment of Gastrointestinal Surgery4-Octyl itaconate (OI) is a novel anti-inflammatory metabolite that exerts protective effects in many various disease models. However, its function in autoimmune hepatitis- (AIH-) associated hepatic injury has not been investigated. In this study, we successfully used concanavalin A (Con A) to establish an AIH-associated liver injury model. Furthermore, we investigated the effect of OI in Con A-induced liver injury and found that OI mitigated Con A-induced histopathological damage. OI administration reduced serum levels of alanine transaminase and aspartate transaminase in Con A-treated mice and attenuated the infiltration of macrophages induced by Con A. Moreover, OI effectively inhibited the expression of proinflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and IL-1β induced by Con A. Furthermore, OI decreased hepatocyte apoptosis and malondialdehyde levels and increased the reduced glutathione/oxidized glutathione ratio in the Con A-induced liver injury model. In addition, we found that OI inhibited Con A-induced hepatocyte apoptosis in vitro, while Nrf2 deletion eliminated this effect. Furthermore, we administrated the Nrf2 inhibitor ML385 in OI+Con A-treated mice and found that ML385 eliminated the protective effect of OI in vivo. In addition, OI inhibited Con A-induced activation of nuclear factor-kappa B (NF-𝜅B) and the expression of proinflammatory cytokines in macrophages. Therefore, OI protected mice from Con A-induced liver damage and may be associated with Nrf2 activation and NF-𝜅B inhibition. Finally, our study revealed that OI inhibited TNF-α, or supernatants from Con A-treated RAW264.7 cells induced hepatocyte apoptosis. In conclusion, our study indicated that OI alleviated Con A-induced hepatic damage by reducing inflammatory response, oxidative stress, and apoptosis.http://dx.doi.org/10.1155/2022/5766434 |
spellingShingle | Wenchang Yang Yaxin Wang Peng Zhang Tao Wang Chengguo Li Xin Tong Xiangyu Zeng Yuping Yin Kaixiong Tao Ruidong Li Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis Mediators of Inflammation |
title | Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis |
title_full | Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis |
title_fullStr | Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis |
title_full_unstemmed | Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis |
title_short | Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis |
title_sort | hepatoprotective role of 4 octyl itaconate in concanavalin a induced autoimmune hepatitis |
url | http://dx.doi.org/10.1155/2022/5766434 |
work_keys_str_mv | AT wenchangyang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT yaxinwang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT pengzhang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT taowang hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT chengguoli hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT xintong hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT xiangyuzeng hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT yupingyin hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT kaixiongtao hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis AT ruidongli hepatoprotectiveroleof4octylitaconateinconcanavalinainducedautoimmunehepatitis |